Camerini A - Search Results

1

An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer.

Pujol JL, Coffy A, Camerini A, Kotsakis A, Mencoboni M, Gusella M, Pasini F, Pezzuto A, Banna GL, Bilir C, Samantas E, Barlesi F, Roch B, Guillou A, Daurès JP. Pujol JL, et al. Among authors: camerini a. PLoS One. 2019 Aug 20;14(8):e0220988. doi: 10.1371/journal.pone.0220988. eCollection 2019. PLoS One. 2019. PMID: 31430345 Free PMC article.

2

Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status.

Camerini A, Valsuani C, Mazzoni F, Siclari O, Puccetti C, Donati S, Rondini M, Tartarelli G, Puccinelli P, Di Costanzo F, Amoroso D. Camerini A, et al. Ann Oncol. 2010 Jun;21(6):1290-1295. doi: 10.1093/annonc/mdp525. Epub 2009 Nov 13. Ann Oncol. 2010. PMID: 19914959 Free article. Clinical Trial.

3

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial).

Camerini A, Puccetti C, Donati S, Valsuani C, Petrella MC, Tartarelli G, Puccinelli P, Amoroso D. Camerini A, et al. BMC Cancer. 2015 May 6;15:359. doi: 10.1186/s12885-015-1354-2. BMC Cancer. 2015. PMID: 25943747 Free PMC article. Clinical Trial.

4

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis.

Bracarda S, Iacovelli R, Boni L, Rizzo M, Derosa L, Rossi M, Galli L, Procopio G, Sisani M, Longo F, Santoni M, Morelli F, Di Lorenzo G, Altavilla A, Porta C, Camerini A, Escudier B; Rainbow Group. Bracarda S, et al. Among authors: camerini a. Ann Oncol. 2015 Oct;26(10):2107-13. doi: 10.1093/annonc/mdv315. Epub 2015 Jul 27. Ann Oncol. 2015. PMID: 26216384 Free article.

5

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.

Cazzaniga ME, Camerini A, Addeo R, Nolè F, Munzone E, Collovà E, Del Conte A, Mencoboni M, Papaldo P, Pasini F, Saracchini S, Bocci G. Cazzaniga ME, et al. Among authors: camerini a. Future Oncol. 2016 Feb;12(3):373-87. doi: 10.2217/fon.15.306. Epub 2015 Nov 19. Future Oncol. 2016. PMID: 26584409 Review.

6

Clinical and radiological features driving patient selection for antiangiogenic therapy in non-small cell lung cancer (NSCLC).

Gridelli C, Camerini A, Pappagallo G, Pennella A, Anzidei M, Bellomi M, Buosi R, Grasso RF. Gridelli C, et al. Among authors: camerini a. Cancer Imaging. 2016 Dec 28;16(1):44. doi: 10.1186/s40644-016-0102-4. Cancer Imaging. 2016. PMID: 28031049 Free PMC article.

7

Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC.

Mencoboni M, Filiberti RA, Taveggia P, Del Corso L, Del Conte A, Covesnon MG, Puccetti C, Donati S, Auriati L, Amoroso D, Camerini A. Mencoboni M, et al. Among authors: camerini a. Anticancer Res. 2017 Jun;37(6):3189-3194. doi: 10.21873/anticanres.11679. Anticancer Res. 2017. PMID: 28551663 Clinical Trial.

8

Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy.

Banna GL, Camerini A, Bronte G, Anile G, Addeo A, Rundo F, Zanghì G, Lal R, Libra M. Banna GL, et al. Among authors: camerini a. Anticancer Res. 2018 Jun;38(6):3689-3697. doi: 10.21873/anticanres.12647. Anticancer Res. 2018. PMID: 29848729 Clinical Trial.

9

Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.

Tibaldi C, Camerini A, Tiseo M, Mazzoni F, Barbieri F, Vittimberga I, Brighenti M, Boni L, Baldini E, Gilli A, Honeywell R, Chartoire M, Peters GJ, Giovannetti E; Italian Oncological Group of Clinical Research (GOIRC). Tibaldi C, et al. Among authors: camerini a. Br J Cancer. 2018 Nov;119(11):1326-1331. doi: 10.1038/s41416-018-0307-3. Epub 2018 Nov 8. Br J Cancer. 2018. PMID: 30405211 Free PMC article.

10

Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis.

Camerini A, Banna GL, Cinieri S, Pezzuto A, Mencoboni M, Rosetti F, Figueiredo A, Rizzo P, Ricci A, Langenhoven L, Santo A, Addeo A, Amoroso D, Barata F. Camerini A, et al. Clin Transl Oncol. 2019 Jun;21(6):790-795. doi: 10.1007/s12094-018-1989-y. Epub 2018 Nov 17. Clin Transl Oncol. 2019. PMID: 30448956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page